Elevation Oncology Inc. (Nasdaq: ELEV) is being bought out by Concentra Biosciences for $0.36 in cash per share, plus a ...

Cathie Wood is bullish on biotech companies using gene sequencing, AI, and CRISPR tech to cure previously untreatable diseases.

Metsera, the obesity-focused biotech, said this morning that its drug candidate targeting the amylin hormone showed marked ...